Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) on Friday, soared 28.00% from the previous trading day, before settling in for the closing price of $1.5. Within the past 52 weeks, IRWD’s price has moved between $0.53 and $5.13.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -47.49%. The company achieved an average annual earnings per share of 1836.40%. With a float of $156.35 million, this company’s outstanding shares have now reached $162.43 million.
The extent of productivity of a business whose workforce counts for 253 workers is very important to gauge.
Ironwood Pharmaceuticals Inc (IRWD) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Ironwood Pharmaceuticals Inc is 3.74%, while institutional ownership is 89.73%. The most recent insider transaction that took place on Aug 11 ’25, was worth 1,105. In this transaction Chief Commercial Officer of this company sold 1,316 shares at a rate of $0.84, taking the stock ownership to the 241,280 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Legal Officer sold 7,754 for $0.84, making the entire transaction worth $6,513. This insider now owns 400,378 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.02 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.1) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1836.40% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Ironwood Pharmaceuticals Inc (IRWD) is currently performing well based on its current performance indicators. A quick ratio of 0.82 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.01. Likewise, its price to free cash flow for the trailing twelve months is 10.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.05, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 0.41 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
The latest stats from [Ironwood Pharmaceuticals Inc, IRWD] show that its last 5-days average volume of 1.68 million was inferior to 2.47 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 45.82%.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 98.49%, which indicates a significant increase from 96.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1337 in the past 14 days, which was higher than the 0.1053 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4188, while its 200-day Moving Average is $1.2820. Now, the first resistance to watch is $2.0367. This is followed by the second major resistance level at $2.1533. The third major resistance level sits at $2.3667. If the price goes on to break the first support level at $1.7067, it is likely to go to the next support level at $1.4933. The third support level lies at $1.3767 if the price breaches the second support level.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
Market capitalization of the company is 311.87 million based on 162,434K outstanding shares. Right now, sales total 351,410 K and income totals 880 K. The company made 85,240 K in profit during its latest quarter, and 23,600 K in sales during its previous quarter.
